Indian Journal of Urology最新文献

筛选
英文 中文
Sestamibi scans for renal oncocytomas: Promising potential, but limitations remain. 肾癌细胞瘤的Sestamibi扫描:有希望的潜力,但局限性仍然存在。
IF 1.3
Indian Journal of Urology Pub Date : 2025-01-01 DOI: 10.4103/iju.iju_355_24
Basil Joy
{"title":"Sestamibi scans for renal oncocytomas: Promising potential, but limitations remain.","authors":"Basil Joy","doi":"10.4103/iju.iju_355_24","DOIUrl":"10.4103/iju.iju_355_24","url":null,"abstract":"","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"41 1","pages":"77-78"},"PeriodicalIF":1.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11778689/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria: A systematic review and meta-analysis of randomized controlled trials. formigenes草酸杆菌治疗原发性高草酸尿的疗效和安全性:随机对照试验的系统回顾和荟萃分析。
IF 1.3
Indian Journal of Urology Pub Date : 2025-01-01 DOI: 10.4103/iju.iju_359_24
Ubaid Khan, Muhammad Mubariz, Hazem Rezq, Abdelrahman Mahmoud, Muhammad Moiz Nasir, Noor Ul Ain, Umar Khan Bazai, Maleeka Zamurad Khan, Mohamed Abuelazm
{"title":"Efficacy and safety of <i>Oxalobacter formigenes</i> in patients with primary hyperoxaluria: A systematic review and meta-analysis of randomized controlled trials.","authors":"Ubaid Khan, Muhammad Mubariz, Hazem Rezq, Abdelrahman Mahmoud, Muhammad Moiz Nasir, Noor Ul Ain, Umar Khan Bazai, Maleeka Zamurad Khan, Mohamed Abuelazm","doi":"10.4103/iju.iju_359_24","DOIUrl":"10.4103/iju.iju_359_24","url":null,"abstract":"<p><strong>Background and objective: </strong>Primary hyperoxaluria (PH), a rare autosomal recessive disorder, results in defective metabolism of oxalate, leading to increased oxalate levels. <i>Oxalobacter formigenes (O. formigenes)</i> is a nonpathological anaerobic bacterium that uses oxalate for its survival and thus decreases the plasma oxalate levels. We aimed to use randomized controlled trials (RCTs) to evaluate the efficacy of <i>O. formigenes</i> in treating PH.</p><p><strong>Methods: </strong>A literature review was conducted for synthesizing the evidence from RCTs on Scopus, Web of Science, Embase, PubMed, and CENTRAL until January 2023. The outcomes were pooled using mean difference (MD) for continuous data and odds ratios (OR) for dichotomous data along with confidence interval (CI). The systematic review is registered with Prospero ID CRD42023404421.</p><p><strong>Results: </strong>We included five RCTs with 208 patients. The pooled analysis did not favor <i>O. formigenes</i> over placebo in reducing the plasma oxalate levels (MD: -0.00 mmol/day; 95% CI: [ - 0.01-0.00]; <i>P</i> = 0.06). Similar results were observed for urinary oxalate levels (MD: -0.01 mmol/day; 95% CI: [ - 0.12-0.10]; <i>P</i> = 0.86). There were no significant adverse events (OR: 0.44; 95% CI: [0.14-1.39]; <i>P</i> = 0.16) or serious adverse events (OR: 0.80; 95% CI: [0.29-2.25]; <i>P</i> = 0.67).</p><p><strong>Conclusion: </strong><i>O. formigenes</i> was ineffective in reducing the serum and urine oxalate levels in patients with PH but has an acceptable safety profile. As PH is a relatively rare disease and few patients consent for the trials, stringent protocols are required in the future to achieve data accuracy pertinent for making conclusive recommendations on the efficacy of <i>O. formigenes</i> in patients with PH.</p>","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"41 1","pages":"11-19"},"PeriodicalIF":1.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11778695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncological outcomes and complications following radical cystectomy with or without neoadjuvant chemotherapy - A retrospective comparative cohort study from a single-center in South India. 肿瘤预后和并发症根治性膀胱切除术伴或不伴新辅助化疗-一项来自印度南部单中心的回顾性比较队列研究
IF 1.3
Indian Journal of Urology Pub Date : 2025-01-01 DOI: 10.4103/iju.iju_214_24
E Selvin Theodore Jayanth, Subhash L Jat, Benedict P Samuel, Ashish Singh, Nirmal Thampi John, Anjana Joel, Rajiv Paul Mukha, Grace Rebecca, Gowri Mahasampath, Chandrasingh Jeyachandra Berry, Antony Devasia, Nitin Kekre, Santosh Kumar
{"title":"Oncological outcomes and complications following radical cystectomy with or without neoadjuvant chemotherapy - A retrospective comparative cohort study from a single-center in South India.","authors":"E Selvin Theodore Jayanth, Subhash L Jat, Benedict P Samuel, Ashish Singh, Nirmal Thampi John, Anjana Joel, Rajiv Paul Mukha, Grace Rebecca, Gowri Mahasampath, Chandrasingh Jeyachandra Berry, Antony Devasia, Nitin Kekre, Santosh Kumar","doi":"10.4103/iju.iju_214_24","DOIUrl":"10.4103/iju.iju_214_24","url":null,"abstract":"<p><strong>Introduction: </strong>Neoadjuvant chemotherapy (NAC) in the management of muscle-invasive bladder carcinoma has not been adopted universally. We studied the oncological outcomes and complications in patients who underwent radical cystectomy (RC) with or without NAC.</p><p><strong>Methods: </strong>A retrospective review of patients who underwent RC with or without NAC from June 2009 to June 2020 was conducted. Oncological outcomes, overall survival (OS) and recurrence-free survival (RFS), complications, and prognostic factors were analyzed.</p><p><strong>Results: </strong>Of the 314 patients who underwent RC, 83 patients received NAC (Group A), and 231 underwent RC alone (Group B). The median age was 58 years. The median follow-up duration was 22 (3-64) and 24 (3-62) months, respectively. The median OS in Group A was significantly higher than Group B (38 months [confidence interval (CI): 34-42] and 32 [CI: 29-35], respectively, [<i>P</i> = 0.033]). The RFS in Groups A and B was 34 (CI: 30-39) and 31 (CI: 28-34) months, respectively (<i>P</i> = 0.47). Higher pathological T stage (T3/4), node positivity and lymphovascular invasion (LVI) were predictors of poor OS and RFS (<i>P</i> < 0.0001). Clavien grades 3/4 complications were comparable (8% vs. 15%; <i>P</i> = 0.19). Glomerular filtration rate (GFR) <60 mL/min/1.73 m<sup>2</sup> was associated with higher postoperative complications in both groups (<i>P</i> = 0.012).</p><p><strong>Conclusion: </strong>The OS with NAC was superior to upfront RC. RFS was, however, comparable. NAC was safe and well-tolerated. Pathologically, higher T stage, node positivity, and LVI were associated with poorer OS and RFS. Low GFR negatively influenced postoperative complications.</p>","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"41 1","pages":"20-27"},"PeriodicalIF":1.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11778687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143067694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of gallium-68 prostate-specific membrane antigen positron emission tomography - Computed tomography/magnetic resonance imaging with histopathology characteristics in carcinoma prostate patients undergoing radical prostatectomy. 行根治性前列腺切除术的前列腺癌患者镓-68前列腺特异性膜抗原正电子发射断层扫描-计算机断层扫描/磁共振成像与组织病理学特征的相关性
IF 1.3
Indian Journal of Urology Pub Date : 2025-01-01 DOI: 10.4103/iju.iju_143_24
P Taur Pratik, Deerush Kannan Sakthivel, S Tiwari Madhav, P Bafna Sandeep, Narasimhan Ragavan
{"title":"Correlation of gallium-68 prostate-specific membrane antigen positron emission tomography - Computed tomography/magnetic resonance imaging with histopathology characteristics in carcinoma prostate patients undergoing radical prostatectomy.","authors":"P Taur Pratik, Deerush Kannan Sakthivel, S Tiwari Madhav, P Bafna Sandeep, Narasimhan Ragavan","doi":"10.4103/iju.iju_143_24","DOIUrl":"10.4103/iju.iju_143_24","url":null,"abstract":"<p><strong>Introduction: </strong>Gallium-68 prostate-specific membrane antigen positron emission tomography (<sup>68</sup>Ga-PSMA PET) is being increasingly used in patients with prostate cancer (PCa) for the staging and detection of lymph node (LN) metastases, despite a lack of prospective, validated evidence. We aimed to investigate the relationship between the PSMA PET findings (maximum standardized uptake [SUV<sub>max</sub>] value) and the final histopathology results (Gleason Grade [GG], and LN positivity) in patients undergoing radical prostatectomy.</p><p><strong>Methods: </strong>This is a single centre, prospective, observational study of 63 consecutive eligible patients treated at a tertiary care centre in India. Patients underwent <sup>68</sup>Ga-PSMA PET computed tomography with fusion magnetic resonance imaging for staging, followed by a Transrectal ultrasound guided prostate biopsy. All patients underwent robotic-assisted radical prostatectomy with extended pelvic LN dissection as per the standard protocol. Clinical parameters and SUV<sub>max</sub> values were collected and analysed.</p><p><strong>Results: </strong>The median preoperative prostate specific antigen (PSA) was 15.0 ng/ml (interquartile range: 9.4-28.0). A statistically significant correlation was observed between the PSA values and the SUV<sub>max</sub> uptake (<i>P</i> < 0.001). Additionally, there was a statistically significant correlation between the SUV<sub>max</sub> of the prostatic lesion and the GG on the radical prostatectomy specimens (<i>P</i> = 0.025), and SUV<sub>max</sub> of LN and LN involvement (<i>P</i> < 0.001). The sensitivity and specificity of the <sup>68</sup>Ga-PSMA PET scan were 77.8% and 88.7%, respectively.</p><p><strong>Conclusions: </strong>SUVmax of the PCa lesion and the GG Group on the final histopathology correlates significantly. There is an increased SUV uptake in Gleason's Score (GS) 8, 9 tumours as compared to GS 6 and 7.</p>","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"41 1","pages":"40-44"},"PeriodicalIF":1.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11778697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment. 编辑评论。
IF 1.3
Indian Journal of Urology Pub Date : 2024-10-01 DOI: 10.4103/iju.iju_342_24
Ravimohan Suryanarayan Mavuduru
{"title":"Editorial Comment.","authors":"Ravimohan Suryanarayan Mavuduru","doi":"10.4103/iju.iju_342_24","DOIUrl":"10.4103/iju.iju_342_24","url":null,"abstract":"","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"40 4","pages":"271-272"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Shah AS. Is rucaparib the definite direction for metastatic prostate cancer? - TRITON3 results decoded. Indian J Urol 2024;40:70-1. Re:Shah AS.鲁卡帕尼是治疗转移性前列腺癌的明确方向吗?- TRITON3 结果解码。Indian J Urol 2024;40:70-1.
IF 1.3
Indian Journal of Urology Pub Date : 2024-10-01 DOI: 10.4103/iju.iju_83_24
Vivaan Dutt, Shalini Shree Krishnamurthy, Anand Raja
{"title":"Re: Shah AS. Is rucaparib the definite direction for metastatic prostate cancer? - TRITON3 results decoded. Indian J Urol 2024;40:70-1.","authors":"Vivaan Dutt, Shalini Shree Krishnamurthy, Anand Raja","doi":"10.4103/iju.iju_83_24","DOIUrl":"10.4103/iju.iju_83_24","url":null,"abstract":"","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"40 4","pages":"289-290"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orthotopic renal autotransplantation: A step forward during postchemotherapy retroperitoneal lymph node dissection for germ cell tumor. 异位肾脏自体移植:生殖细胞瘤化疗后腹膜后淋巴结清扫术向前迈进了一步。
IF 1.3
Indian Journal of Urology Pub Date : 2024-10-01 DOI: 10.4103/iju.iju_48_24
Akash Mor, Ajit Gujela, Sachin Patel, Vineet Kumar, Gagan Prakash
{"title":"Orthotopic renal autotransplantation: A step forward during postchemotherapy retroperitoneal lymph node dissection for germ cell tumor.","authors":"Akash Mor, Ajit Gujela, Sachin Patel, Vineet Kumar, Gagan Prakash","doi":"10.4103/iju.iju_48_24","DOIUrl":"10.4103/iju.iju_48_24","url":null,"abstract":"<p><p>We present the first and a rare case of orthotopic renal auto-transplantation in the management of postchemotherapy residual retroperitoneal mass encasing the left renal vessels but sparing the parenchyma in a 24-year-old patient with Stage IIIC nonseminomatous germ cell tumor after 4 cycles of chemotherapy. Immediate postoperative and 6 months' follow-up renograms confirmed the maintained glomerular filtration rate of the transplanted kidney with no residual disease. This case report shows the feasibility of renal autotransplantation in carefully selected patients as they are young and have long-term survival.</p>","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"40 4","pages":"273-275"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment. 编辑评论。
IF 1.3
Indian Journal of Urology Pub Date : 2024-10-01 DOI: 10.4103/iju.iju_308_24
Venkat Arjunrao Gite
{"title":"Editorial Comment.","authors":"Venkat Arjunrao Gite","doi":"10.4103/iju.iju_308_24","DOIUrl":"10.4103/iju.iju_308_24","url":null,"abstract":"","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"40 4","pages":"259"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Purushothaman J, Kalra S, Dorairajan LN, Selvarajan S, Sreerag KS, Aggarwal D. Intravesical bupivacaine in reducing catheter-related bladder discomfort and lower urinary tract symptoms after transurethral surgery: A randomized controlled trial. Indian J Urol 2024;40:161-6. Re:Purushothaman J, Kalra S, Dorairajan LN, Selvarajan S, Sreerag KS, Aggarwal D. 经尿道手术后膀胱内布比卡因减少导尿管相关膀胱不适和下尿路症状的随机对照试验:随机对照试验。Indian J Urol 2024;40:161-6.
IF 1.3
Indian Journal of Urology Pub Date : 2024-10-01 DOI: 10.4103/iju.iju_273_24
Kirti Singh, Swarnendu Mandal, Manoj K Das, Prasant Nayak
{"title":"Re: Purushothaman J, Kalra S, Dorairajan LN, Selvarajan S, Sreerag KS, Aggarwal D. Intravesical bupivacaine in reducing catheter-related bladder discomfort and lower urinary tract symptoms after transurethral surgery: A randomized controlled trial. Indian J Urol 2024;40:161-6.","authors":"Kirti Singh, Swarnendu Mandal, Manoj K Das, Prasant Nayak","doi":"10.4103/iju.iju_273_24","DOIUrl":"10.4103/iju.iju_273_24","url":null,"abstract":"","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"40 4","pages":"287-288"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Round up. 综述。
IF 1.3
Indian Journal of Urology Pub Date : 2024-10-01 DOI: 10.4103/iju.iju_357_24
Swarnendu Mandal
{"title":"Round up.","authors":"Swarnendu Mandal","doi":"10.4103/iju.iju_357_24","DOIUrl":"10.4103/iju.iju_357_24","url":null,"abstract":"","PeriodicalId":47352,"journal":{"name":"Indian Journal of Urology","volume":"40 4","pages":"215-217"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信